| Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition M Vaccari, SN Gordon, S Fourati, L Schifanella, NPM Liyanage, ... Nature medicine 22 (7), 762-770, 2016 | 214 | 2016 |
| Leishmaniasis: new insights from an old and neglected disease S Antinori, L Schifanella, M Corbellino European journal of clinical microbiology & infectious diseases 31, 109-118, 2012 | 178 | 2012 |
| Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years S Antinori, L Schifanella, M Million, L Galimberti, L Ferraris, L Mandia, ... International Journal of Infectious Diseases 16 (9), e649-e662, 2012 | 78 | 2012 |
| HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition M Vaccari, S Fourati, SN Gordon, DR Brown, M Bissa, L Schifanella, ... Nature medicine 24 (6), 847-856, 2018 | 66 | 2018 |
| Cutting edge: mouse SARS-CoV-2 epitope reveals infection and vaccine-elicited CD8 T cell responses V Joag, S Wijeyesinghe, JM Stolley, CF Quarnstrom, T Dileepan, ... The Journal of Immunology 206 (5), 931-935, 2021 | 42 | 2021 |
| Regulatory and helper follicular T cells and antibody avidity to simian immunodeficiency virus glycoprotein 120 MJ Blackburn, M Zhong-Min, F Caccuri, K McKinnon, L Schifanella, ... The Journal of Immunology 195 (7), 3227-3236, 2015 | 42 | 2015 |
| Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity C Martino, BP Kellman, DR Sandoval, TM Clausen, CA Marotz, SJ Song, ... BioRxiv, 2020.08. 17.238444, 2020 | 35 | 2020 |
| Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis AT Gustin, AR Thurman, N Chandra, L Schifanella, M Alcaide, ... American journal of obstetrics and gynecology 226 (2), 225. e1-225. e15, 2022 | 34 | 2022 |
| Boosting of ALVAC-SIV vaccine-primed macaques with the CD4-SIVgp120 fusion protein elicits antibodies to V2 associated with a decreased risk of SIVmac251 acquisition SN Gordon, NPM Liyanage, MN Doster, M Vaccari, ... The Journal of Immunology 197 (7), 2726-2737, 2016 | 32 | 2016 |
| Diagnosis and therapy for hospitalized imported malaria in adults in Italy S Antinori, B Cigardi, L Galimberti, G Orlando, L Schifanella, L Milazzo, ... Journal of travel medicine 18 (6), 379-385, 2011 | 25 | 2011 |
| Alu retrotransposons and COVID-19 susceptibility and morbidity M Li, L Schifanella, PA Larsen Human genomics 15, 1-11, 2021 | 24 | 2021 |
| Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism RK Cheu, AT Gustin, C Lee, L Schifanella, CJ Miller, A Ha, C Kim, ... PLoS pathogens 16 (12), e1009024, 2020 | 24 | 2020 |
| Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac251 infection of macaques NPM Liyanage, SN Gordon, MN Doster, P Pegu, M Vaccari, N Shukur, ... Virology 450, 359-368, 2014 | 24 | 2014 |
| ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type L Schifanella, SW Barnett, M Bissa, V Galli, MN Doster, M Vaccari, ... PLoS pathogens 15 (12), e1008121, 2019 | 21 | 2019 |
| Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition G Gorini, S Fourati, M Vaccari, MA Rahman, SN Gordon, DR Brown, ... PLoS pathogens 16 (3), e1008377, 2020 | 16 | 2020 |
| Myeloid cell crosstalk regulates the efficacy of the DNA/ALVAC/gp120 HIV vaccine candidate M Vaccari, S Fourati, DR Brown, I Silva de Castro, M Bissa, L Schifanella, ... Frontiers in immunology 10, 1072, 2019 | 16 | 2019 |
| Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates IS de Castro, G Gorini, R Mason, J Gorman, M Bissa, MA Rahman, ... Iscience 24 (2), 2021 | 15 | 2021 |
| Adjuvant‐mediated enhancement of the immune response to HIV vaccines S Ratnapriya, E Perez‐Greene, L Schifanella, A Herschhorn The FEBS Journal 289 (12), 3317-3334, 2022 | 14 | 2022 |
| Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women A Gustin, R Cromarty, L Schifanella, NR Klatt Seminars in immunology 51, 101482, 2021 | 13 | 2021 |
| The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis L Schifanella, J Anderson, G Wieking, PJ Southern, S Antinori, M Galli, ... The Journal of Infectious Diseases 227 (11), 1245-1254, 2023 | 12 | 2023 |